The Collaboration
Where wellbeing meets peptide science.
Superdose × Celia is a partnership between a wellbeing brand and a practitioner-led
peptide platform — built to make clinically formulated, personalized care accessible
to the way you actually live.
Superdose
Superdose curates the science of aging well — sourcing pharmacy-grade compounds and
pairing them with a wellbeing-first point of view. The goal is simple: more healthy
years, grounded in evidence.
Celia
Celia brings the clinical infrastructure — a network of practitioners, rigorous
formulation standards, and 1:1 protocols that turn a peptide into a plan tailored to you.
What we share
01 Clinical rigor
Every formulation is grounded in peptide research — selected for clinical evidence,
purity, and measurable outcomes rather than trend.
02 Personalized protocols
Celia's practitioner network pairs each peptide with a 1:1 protocol, so your plan
reflects your goals, biology, and the way you want to age.
03 Wellbeing-first
Superdose brings the wellbeing lens — from mitochondrial support to immune balance
and skin renewal — designed for the long arc of health.
A trusted US partner
Celia is a trusted, US-based company. Their peptides are produced with a domestic,
local Active Pharmaceutical Ingredient (API) supply chain and excellent infrastructure —
meaning tighter quality control, full chain-of-custody, and reliable, fast fulfillment
compared with overseas sourcing.
The Superdose × Celia collaboration pairs Superdose's wellbeing-focused brand with
Celia's clinical formulation and manufacturing backbone.
Made in the USA in an FDA-registered facility that follows current
Good Manufacturing Practices (cGMP).
FDA facility registration does not mean the products are FDA-approved.
cGMP compliance does not establish clinical efficacy or guarantee safety.
Why local API & infrastructure matters
US-based API sourcing and in-house infrastructure reduce supply-chain risk and
improve batch-to-batch consistency. They support proper testing and certificates
of analysis (COAs), and they enable practitioner-guided, personalized programs —
so what's in the vial is verified, traceable, and matched to a plan built around you.
The peptide market
The wellbeing and peptide-therapeutics market is growing rapidly. Interest in
healthspan, metabolic health, recovery, and personalized medicine is driving rising
demand from both consumers and clinicians. As the category matures, the emphasis is
shifting toward quality, transparency, and evidence — the standards this collaboration
is built around.
Regulation & the evolving landscape
Peptides occupy an evolving regulatory space in the United States. The FDA has been
re-examining and reclassifying certain compounded substances over time — including
placing some peptides on lists that can restrict compounding under sections 503A and
503B — and this landscape continues to shift. Specifics can change, so treat this as
general context rather than a definitive statement of current rules.
Because requirements vary by compound and continue to develop, we recommend working
with licensed practitioners who can advise on what is appropriate and available for
your situation.
Disclaimer
This information is provided for general, informational purposes only and is not
medical or legal advice. It does not constitute a recommendation to use any specific
compound. Always consult a qualified, licensed healthcare professional before beginning
any peptide or wellbeing program.